Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.

Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.

The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.

Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.

Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.

Scaling up nanoparticle production could help scientists test new cancer treatments.

Graduate student and MathWorks fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.

When scientists stimulated cells to produce a protein that helps “water bears” survive extreme environments, the tissue showed much less DNA damage after radiation treatment.

When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.

By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.